CRT-600.04 Efficacy Of Alirocumab And Evolocumab In Lowering Low-density Lipoprotein Cholesterol To Less Than 70 mg/dL In 107 High-risk Hypercholesterolemic Patients
Min, Sarah, MD, Goldenberg, Naila, MD, Glueck, Charles, MD, Wang, Ping, PhD
Published in JACC. Cardiovascular interventions (13.02.2017)
Published in JACC. Cardiovascular interventions (13.02.2017)
Get full text
Journal Article
CRT-600.05 Eligibility for PCSK9 Inhibitor Treatment in 1090 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center with LDL Cholesterol >=70 mg/dl Despite Maximal Tolerated Cholesterol Lowering Therapy
Lee, Kevin, MD, Min, Sarah, MD, Prince, Marloe, MD, Glueck, Charles, MD, Wang, Ping, PhD, Lee, Kenneth
Published in JACC. Cardiovascular interventions (13.02.2017)
Published in JACC. Cardiovascular interventions (13.02.2017)
Get full text
Journal Article
Efficacy, Safety, LDL Cholesterol Lowering, and 10-Year ASCVD Risk Reduction: Alirocumab and Evolocumab in Addition to Maximal Tolerated LDL Lowering
D'Souza, Kenneth, MD, Rothschild, Matan, MD, Jetty, Vybhav, MD, Anaba, Uzoma, MD, Min, Sarah, MD, Goldenberg, Naila, MD, Wang, Ping, PhD, Glueck, Charles, MD
Published in Journal of clinical lipidology (01.05.2017)
Published in Journal of clinical lipidology (01.05.2017)
Get full text
Journal Article
Treatment of Severe Hypertriglyceridemia (500 to >/= 2000 mg/dL) in 636 Patients
Jarman, Michael, Rothschild, Matan, MD, Lee, Kevin, MD, Schlam, Ilana, MD, Mahida, Chris, MD, Makadia, Frini, MD, Milgrom, Alexander, MD, Min, Sarah, MD, Huda, Ali, MD, Goldenburg, Naila, MD, Wang, Ping, PhD, Glueck, C.J., MD
Published in Journal of clinical lipidology (01.05.2017)
Published in Journal of clinical lipidology (01.05.2017)
Get full text
Journal Article